CD6

CD6

CD6 Molekülinformation

Molecule Name
T-cell differentiation antigen CD6
Molekülalias
CD6,TP120,T12
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel1
Höchste Forschungs- und EntwicklungsphaseApproved
Target-Alias
T12,CD6,CD6 Molecule,TP120,T-Cell Differentiation Antigen CD6,CD6 Antigen
Molekülhintergrund
CD6 (Cluster of Differentiation 6) is a transmembrane protein primarily expressed on T-lymphocytes and certain other immune cells. Structurally, it is characterized by three scavenger receptor cysteine-rich (SRCR) domains and a binding site for an activated leukocyte cell adhesion molecule (ALCAM). Functionally, CD6 is critical for the continuation of T cell activation and exhibits scavenger receptor activity. Aberrant CD6 function is associated with diseases such as Multiple Sclerosis. Its paralog is DMBT1.

CD6 Produktliste

Species
  • Cynomolgus(3)
  • Human(3)
Tag
  • Fc Tag & Avi Tag(2)
  • His Tag(2)
  • His Tag & Avi Tag(2)
Host
  • HEK293(6)
Conjugate
  • Biotin-labeled(4)
  • Unconjugated(2)
Grade
  • RUO(6)
Low Endotoxin
  • No(6)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
CD6
HOTAvitag
CD6-H82E3
Biotinylated Human CD6 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
CD6
Human CD6 / TP120 Protein, His Tag
Human
HEK293
SDS-PAGE

$340.00

100ug
CD6
Cynomolgus CD6 Protein, His Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$395.00

100ug
CD6
Avitag
CD6-C82E3
Biotinylated Cynomolgus CD6 Protein, His,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
CD6
Avitag
CD6-C82F3
Biotinylated Cynomolgus CD6 / TP120 Protein, Fc,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
CD6
Avitag
CD6-H82F3
Biotinylated Human CD6 / TP120 Protein, Fc,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
You Have Viewed 1-6 Of 6 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells therapy (City of Hope Medical Center)Phase 1 ClinicalCity Of Hope National Medical Center
Diabetes Mellitus, Type 1; Graft vs Host Disease; Hemic and Lymphatic Diseases
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
ItolizumabT-1-hT; EQ-001; T-1-h; h-T1; Bmab-600; Bmab600ApprovedCenter Of Molecular ImmunologyAlzumabIndiaPlaque psoriasisBiocon Ltd2013-01-01
Asthma; Coronavirus Disease 2019 (COVID-19); Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Lupus Nephritis; Plaque psoriasis; Psoriasis; Respiratory Distress Syndrome, Adult
Details
Customer Reviews
  • g***t2025-11-28
    We use Human CD16 from AcroBiosystems since many years now for in vitro characterization of antibodies and we are very happy to have well documented certificate to set up our experiments.